Adams Brian bought KYMR
March 2, 2026 · Form 4 insider transaction
Adams Brian bought 8,250 shares of Kymera Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,250
Price
$0.00
Total value
N/A
InsiderAdams Brian
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after8,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this stock option shall vest in fourty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date.